CSPC Pharmaceutical says nintedanib esilate powder approved for clinical trials in China
Published on 01/02/2026 at 08:58 am EST
Reuters
Share

Share
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.11 HKD | -0.30% |
|
+4.66% | +19.93% |
| Feb. 11 | China charges former AstraZeneca regional head Leon Wang | RE |
| Feb. 03 | Asian Stock Markets Rally on Renewed AI Fervor; Tokyo, Seoul Strike Zeniths Again | MT |
Published on 01/02/2026 at 08:58 am EST


Select your edition
All financial news and data tailored to specific country editions